Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study

Fig. 4

Pathological response rate and DFS. a It displays the tumor pathological regression graded in each group. There were 15 cases of TRG0 (pCR), 15 cases of TRG1, 13 cases of TRG2, and 7 cases of TRG3 in NATRACE-CRT group, while 8 cases of TRG0 (pCR), 7 cases of TRG1, 17 cases TRG2, and 13 cases of TRG3 were found in the NA-CRT group. b It shows that the TRG0 + 1 patient in NATRACE-CRT group had significantly more than patients in NA-CRT group. c Kaplan–Meier survival analysis of DFS in two groups, p = 0.0797

Back to article page